Across 460 first-hand reports, people mentioned a side effect 98 times (about 21 per 100 reports). The most common: nausea, fatigue, stomach issues. User reports show what people notice — they can't tell you whether Retatrutide is safe for you.
High-risk compound. Not an approved supplement; serious and sometimes irreversible risks, banned in sport, may be restricted where you live.
“I’ve tried Reta and it melted fat away at 1mg - I really disliked the increased heart rate (and it was only 8bpm) and the nuking of my HRV.”
“I lost 115 lbs in the last year (260 → 145)...retatrutide seemed to finally address my insulin resistance.”
“I started my peptide journey begining of April. Started reta at .5mg a week...Within 8 weeks I lost 30 pounds. Positives: daily knee pain is completely gone.”
“I've lost about 15 pounds while preserving (if not still putting on some) muscle mass.”
“I've stayed at 6 mg/week. Clinical trials have evaluated doses up to 12 mg/week, but I haven't felt the need to increase beyond 6 mg.”
“I lost approximately 80 pounds (265-185) and dramatically improved my overall health.”
Conclusion: GLP-1 RAs and co-agonists are efficacious for weight loss, with reported safety concerns predominantly gastrointestinal in nature, when used among adults with overweight or obesity and without diabetes.
Conclusion: GLP-1 RAs carry a slightly increased risk of pancreatitis, which is not significant when stratified by background medication use. Overall risk for pancreatic cancer was not observed, but a slight association was found when stratified with background medications. However, this difference is likely minimal, given the numerous studies excluded from the meta-analysis where both treatment arms had zero events.